Inspire Medical Systems, Inc. (INSP)
INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?
Inspire Medical stock's 39.7% three-month surge is driven by the easing of reimbursement pressures, increasing Inspire V adoption and Project Horizon targeting longer-term expansion.
Here's Why You Should Add INSP Stock to Your Portfolio Now
Inspire Medical's Inspire V adoption, clinical evidence and underpenetrated OSA market support growth despite coding and reimbursement headwinds.
Is INSP a Buy as Margins Improve but Reimbursement Risks Persist?
Inspire Medical's vast sleep apnea opportunity, rising margins and debt-free balance sheet support patience as reimbursement issues weigh on procedures.
INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease
Inspire Medical raised its 2026 outlook after a Q2 beat, as Inspire V mix and cost control offset weak U.S. procedure activity.
INSP's 28.1% Past-Month Rally Raises a Key Question for Investors
Inspire Medical shares jumped 28.1% as an earnings beat, raised 2026 guidance and estimate revisions offset reimbursement pressure.
Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Up
INSP beats second-quarter estimates, raises its 2026 outlook and sees shares jump despite U.S. reimbursement pressures and lower revenues.
Inspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call Transcript
Inspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call Transcript
Inspire Medical Systems Q2 Earnings Call Highlights
Inspire Medical Systems NYSE: INSP reported second-quarter revenue of $200.6 million, down 7.6% from a year earlier, as coding and reimbursement disruptions continued to affect procedure volumes. The company said results exceeded its internal expectations for profitability and cash flow, prompting it to raise its full-year outlook for revenue, adjusted operating margin and adjusted earnings per share.
Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics
The headline numbers for Inspire (INSP) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Inspire Medical Systems (INSP) Q2 Earnings and Revenues Beat Estimates
Inspire Medical Systems (INSP) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of a loss of $0.22 per share. This compares to earnings of $0.45 per share a year ago.
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
Inspire Medical's Inspire V rollout, broader approvals and clinical evidence support growth despite coding and reimbursement pressures.
Inspire Medical Systems, Inc. (INSP) Presents at Wells Fargo 2026 MedTech Innovation Spotlight Transcript
Inspire Medical Systems, Inc. (INSP) Presents at Wells Fargo 2026 MedTech Innovation Spotlight Transcript
